Marc Iacobucci
Managing Director at Nanology
Marc Iacobucci's Professional Contact Details
Email (Verified)
****
HQ
(817) 900-4002
Location
Fort Worth, Texas, US
Company
Nanology
Person Seniority
director
Marc Iacobucci's Current Company Details
NanOlogyâ„¢ is a clinical-stage pharmaceutical development company, formed between DFB, CritiTech, and US Biotest in 2015, to finance and develop a patented nanoparticle platform aimed at transfor...
NanOlogyâ„¢ is a clinical-stage pharmaceutical development company, formed between DFB, CritiTech, and US Biotest in 2015, to finance and develop a patented nanoparticle platform aimed at transforming the treatment of cancer and other serious illnesses. NanOlogy is advancing a broad clinical development program to evaluate a patented nanoparticle platform across multiple indications including ovarian, prostate, and pancreatic cancers, pancreatic mucinous cysts, cutaneous metastases, and actinic keratosis (under affiliate, Soria). The platform is also showing promise for treatment of lung cancer and bladder cancer based on preclinical work. Please visit our website for more information on NanOlogy.
Founded Year
2015
Organization Website
nanology.us
Current Technologies
blue host
nginx
google analytics
mobile friendly
wordpress org
google font api
pharmaceuticals
medical
Marc Iacobucci's Work History and Education
NanOlogy
Managing Director
2015 - Present
Colleagues at Nanology
Prospect on LinkedIn
Find emails on Linkedln, Sales Navigator, AngelList, CrunchBase, Google etc.
Download
Extension
Other people in our database: